Summitry LLC Boosts Holdings in Agilent Technologies, Inc. $A

Summitry LLC boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 2.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 607,839 shares of the medical research company’s stock after acquiring an additional 16,097 shares during the period. Agilent Technologies comprises 3.2% of Summitry LLC’s portfolio, making the stock its 12th largest holding. Summitry LLC’s holdings in Agilent Technologies were worth $71,731,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of A. Stone House Investment Management LLC acquired a new position in shares of Agilent Technologies during the 1st quarter worth approximately $30,000. Ransom Advisory Ltd acquired a new stake in Agilent Technologies during the 1st quarter valued at $32,000. Central Pacific Bank Trust Division purchased a new position in Agilent Technologies during the second quarter worth $33,000. Zions Bancorporation National Association UT purchased a new position in Agilent Technologies during the first quarter worth $38,000. Finally, Costello Asset Management INC acquired a new position in shares of Agilent Technologies in the first quarter worth $47,000. 87.41% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 12,490 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the completion of the sale, the chief executive officer directly owned 33,448 shares in the company, valued at $5,017,200. The trade was a 27.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.26% of the stock is currently owned by company insiders.

Agilent Technologies Trading Up 0.0%

A stock opened at $146.90 on Friday. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The company has a market cap of $41.65 billion, a price-to-earnings ratio of 34.48, a PEG ratio of 4.67 and a beta of 1.29. The business has a fifty day simple moving average of $137.63 and a 200-day simple moving average of $123.89. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were issued a $0.248 dividend. The ex-dividend date was Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.24%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on A shares. Rothschild Redb raised Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. JPMorgan Chase & Co. raised their price target on shares of Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Robert W. Baird boosted their price objective on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research report on Thursday, August 28th. Evercore ISI raised their target price on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 7th. Finally, Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $149.62.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.